The pathology of breast cancer and the role of the histopathology laboratory

Clinical Oncology

Volumn 17, Issue 4, 2005, Pages 234-239

  Hanby, Andrew Malcolm ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Diagnosis; Histopathology; Predictive factors; Prognostic factors; Quality; Taxonomy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MUCIN 1; MUCIN 2; UVOMORULIN;

BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER SCREENING; CARCINOMA IN SITU; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LUNG CARCINOMA; MEDICAL AUDIT; MYOEPITHELIUM; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; REVIEW; TAXONOMY;

EID: 19144370774     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2005.02.009     Document Type: Article

References (41)

1. H.F. Dvorak Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing N Engl J Med 315 1986 1650-1659
2. H. Denley S.E. Pinder C. Elston et al. Preoperative assessment of prognostic factors in breast cancer J Clin Pathol 54 2001 20-24
3. R.R. Millis A.M. Hanby H.A. Oberman The breast In: S.S. Sternberg editor. Diagnostic surgical pathology 3rd edn 1999 Raven Press New York 319-385
4. L.W. Turnbull S. Barker G.P. Liney Comparative effectiveness of magnetic resonance imaging in breast cancer (COMICE trial) Breast Cancer Res 2003 39
5. S.R. Wellings H.M. Jensen R.G. Marcum Atlas of subgross pathology of the human breast with special reference to possible cancerous lesions J Natl Cancer Inst 55 1975 231-273
6. O.T. Lampejo D.M. Barnes P. Smith et al. Evaluation of infiltrating carcinomas with a DCIS component: Correlation of the histologic type of the in situ component with grade of the infiltrating component Semin Diagn Pathol 11 1994 215-222
7. W. Boecker H. Buerger K. Schmitz et al. Ductal epithelial proliferations of the breast: A biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns J Pathol 195 2001 415-421
8. C.M. Quinn J.L. Ostrowski Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast J Clin Pathol 50 1997 596-599
9. R.M. Millis Classification of ductal carcinoma in situ of the breast Adv Anat Pathol 3 1996 114-129
10. A.G. Douglas-Jones S.K. Gupta R.L. Attanoos et al. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): Correlation with grade of associated invasive carcinoma Histopathology 29 1996 397-409
11. N. Bijker J.L. Peterse L. Duchateau et al. Risk factors for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: Analysis of European organisation and treatment of Cancer trial 10893 J Clin Oncol 19 2001 2263-2271
12. I.O. Ellis M. Galea N. Broughton et al. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long term follow-up Histopathology 20 1992 479-489
13. S.R. Lakhani Molecular genetics of solid tumours: Translating research into clinical practice. What we could do now: Breast cancer Mol Pathol 54 2001 281-284
14. A.M. Hanby The role of the subspecialized histopathologist in the treatment of invasive breast cancer: Determination of distinct biologies of clinical relevance Curr Med Lit Breast Cancer 11 1999 85-90
15. J.T. O'Connell Z. Shao E. Drori et al. Altered mucin expression is a field change that accompanies mucinous (colloid) breast carcinoma Hum Pathol 29 1998 1517-1523
16. I.S. Fentiman R.R. Millis P. Smith et al. Mucoid breast carcinomas: histology and prognosis Br J Cancer 75 1997 1061-1065
17. G. Berx A.M. Cleton-Jansen K. Strumane et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain Oncogene 13 1996 1919-1925
18. S. Droufakou V. Deshmane A. Hanby et al. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast Int J Cancer 92 2001 404-408
19. A.I.M. Barth I.S. Nathke W.J. Nelson Cadherins, catenins and APC protein: Interplays between cytoskeletal complexes and signalling pathways Curr Opin Cell Biol 9 1997 683-690
20. B.M. Gumbiner Cell adhesion: The molecular basis of tissue architecture and morphogenesis Cell 84 1996 345-357
21. R. Roylance P. Gorman W. Harris et al. Comparative hybridisation of breast tumours stratified by histological grade reveals new insights into the biological progression of breast cancer Cancer Res 59 1999 1433-1436
22. C.W. Elston I.O. Ellis Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up Histopathology 19 1999 403-410
23. M.H. Galea R.W. Blamey C.E. Elston The Nottingham prognostic index in primary breast cancer Breast Cancer Res Treat 22 1992 207-219
24. I. Balslev C.K. Axelsson K. Zedeler The Nottingham Prognostic index applied to 9,149 patients from the Danish Breast Cancer Cooperative Group (DBCCG) Breast Cancer Res Treat 32 1994 281-290
25. C. Charpin S. Garcia P. Bonnier et al. Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas Am J Clin Pathol 109 1997 431-438
26. H. Oka H. Shiozaki K. Kobayashi et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis Cancer Res 53 1993 1696-1701
27. P. Lipponen E. Saarelainen H. Ji et al. Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer J Pathol 174 1994 101-109
28. A.P. Soler K.A. Knudsen H. Salazar P-cadherin expression in breast carcinomas indicates poor survival Cancer 86 1999 1263-1272
29. C.E. Gillett D.W. Miles K. Ryder et al. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast J Pathol 193 2001 433-441
30. R.M. Elledge C.K. Osborne Oestrogen receptors and breast cancer BMJ 314 1997 1843-1844
31. M.M. Goldenberg Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer Clin Ther 21 1999 309-318
32. J.P. Sloane R. Ellman T.J. Anderson et al. Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. national external quality assessment (EQA) scheme Eur J Cancer 30A 1994 1414-1419
33. A. Rhodes B. Jasani D.M. Barnes et al. Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: Interlaboratory variance in the sensitivity of detection and evaluation of scoring systems J Clin Pathol 53 2000 125-130
34. P.C. Roche V.J. Suman R.B. Jenkins et al. Concordance between local and central laboratory testing in the breast intergroup trial N9831 J Natl Cancer Inst 94 2002 855-857
35. I.O. Ellis J. Bartlett M. Dowsett et al. Best practice No 176: Updated recommendations for HER2 testing in the UK J Clin Pathol 57 2004 252-261
36. C. Jones E. Ford C. Gillett et al. Molecular cytogenetic identification of subgroups of grade III invasive ductal carcinomas with different clinical outcomes Clin Cancer Res 10 2004 5988-5997
37. T. Sorlie C.M. Perou R. Tibshirani et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 2001 10869-10874
38. M.J. Van-de-Vijver Y.D. He L.J. Van-Veer et al. A gene-expression signature as a predictor of survival in breast cancer N Engl J Med 347 2002 1999-2009
39. C.M. Perou S.S. Jeffrey M. Van-De-Rijn et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers Proc Natl Acad Sci U S A 96 1999 9212-9217
40. F. Bertucci P. Finetti J. Rougemont et al. Gene expression profiling for molecular characterisation of inflammatory breast cancer and prediction of response to chemotherapy Cancer Res 64 2004 8558-8565
41. J.I. Bell Clinical research is dead; long live clinical research Nature Med 5 1999 477-478